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AbstrACt
Introduction Although diabetes distress is found 
to be associated with decreased glycaemic control 
among adults with type 1 diabetes, the psychological 
and emotional impact of living with the condition 
is often not recognised and often under-reported 
in diabetes care. Therefore, regular assessment of 
diabetes distress is recommended. Assessment of 
diabetes distress using patient-reported outcome 
measures (PROMs) in clinical practice has the 
potential to enhance care for people with diabetes by 
identifying problems and improving patient–clinician 
communication. In this study protocol, we describe a 
pilot randomised controlled trial (RCT) aiming to test 
the feasibility of all components of an empowerment-
based intervention using PROMs as dialogue support 
in clinical diabetes consultations, and to address the 
uncertainties associated with running a fully powered 
evaluation study.
Methods and analysis We will undertake a two-
arm pilot RCT of an intervention using the Problem 
Areas In Diabetes (PAID) scale in clinical diabetes 
consultations in order to conclude whether a fully 
powered trial is appropriate and/or feasible. The study 
will also include qualitative indepth interviews with 
participants and healthcare providers. Our objectives 
are to (1) evaluate the recruitment procedures 
and attrition rates; (2) evaluate the performance 
of the randomisation procedure; (3) evaluate the 
participants’ mean scores on the outcome measures 
before and after the intervention; (4) evaluate if the 
intervention consultations are acceptable and feasible; 
and (5) explore patients’ and healthcare providers’ 
experiences with the use of PAID as dialogue support 
and empowerment-based communication skills in 
clinical diabetes consultations. The quantitative data 
analysis includes descriptive statistics (frequencies, 
percentages, means, SD and CI). For the qualitative 
data, we will perform thematic analysis.
Ethics and dissemination Ethical approval has been 
obtained from the Western Norway Regional Committee 
for Medical and Health Research Ethics (2017/1506/
REC west). We will present the findings from the study 
phases at national and international conferences and 
submit manuscripts to peer-reviewed journals and 
popular science journals. 
trial registration number NCT03471104; Pre-results.
IntroduCtIon 
The management of type 1 diabetes (T1D) is 
complex, and people living with the condition 
need to make numerous daily choices related 
to their medical treatment.1 2 They need to 
monitor their blood glucose and administer 
insulin several times each day. The burden of 
living with T1D remains a challenge despite 
new insulin types and advances in insulin 
delivery and glucose monitoring technolo-
gies.3 Many Norwegian adults with T1D do 
not achieve the recommended treatment 
goals for glycaemic control.4 5 This poor goal 
attainment might be due to inappropriate 
choice of insulin regimen for the individual, 
but research has also shown psychological 
strengths and limitations of this study
 ► This is a study with the potential to provide new 
knowledge about the use of patient-reported out-
come measures (PROMs) as dialogue support in 
clinical diabetes consultations among patients with 
type 1 diabetes.
 ► The use of the Medical Research Council’s frame-
work as a guide for the development of study inter-
vention initiatives like this is a strength because the 
feasibility and uncertainties related to a fully pow-
ered randomised controlled trial (RCT) can be illu-
minated before a resource-intensive fully powered 
RCT is conducted.
 ► A key challenge includes possible contamination of 
the control group, although the completed PROMs 
will not be available in the electronic patient records 
of the participants in the control group.
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and emotional aspects as important barriers for satisfac-
tory diabetes self-management.6 
The psychological and emotional impact of living with 
diabetes is often unrecognised and/or under-reported 
in diabetes care.7 8 Diabetes distress, which reflects the 
emotional response to the burden, worries, anxieties, frus-
trations and stressors associated with managing diabetes 
in everyday life,9 10 is found to be associated with decreased 
glycaemic control.11 12 Therefore, regular assessment of 
diabetes distress is recommended.13 Such assessment is 
considered feasible and beneficial to promote the recog-
nition of psychological and emotional issues that affect 
diabetes self-management.9 14
Collecting patient-reported outcome measures 
(PROMs) involves asking people to complete question-
naires concerning the impact of their condition and its 
treatment on their health.15 The integration of PROMs 
in clinical practice has the potential to improve care 
for people with diabetes and other chronic conditions 
by screening for and identifying problems, monitoring 
progress over time, improving patient–clinician commu-
nication and enabling people to become more involved 
in managing their own health.16 17 However, using PROMs 
in itself may not affect health outcomes. The collection 
of PROMs should be accompanied by a discussion of 
results to elaborate on any problems identified by the 
assessment.14 17 Previous research has shown that the use 
of PROMs to monitor diabetes psychological distress and 
general well-being followed by a discussion of outcomes 
improves psychological well-being in both adults and 
youth with diabetes.14 18 19 In the Cross-National Diabetes 
Attitudes, Wishes, and Needs (DAWN) Monitoring of Indi-
vidual Needs in Diabetes (MIND) study,14 the skills used 
in discussions of PROMs data regarding diabetes distress 
and well-being were based on empowerment theory 
and patient-centred communication. Empowerment 
in nursing and healthcare is defined as a motivational 
approach and process using specific counselling and 
communication techniques to assist patients in making 
health-promoting behaviour changes.20 The approach 
is patient-centred, with the healthcare providers facili-
tating and providing information and knowledge to assist 
the patients in taking informed decisions. The desired 
outcomes in the empowerment process are control and 
self-determination. A systematic review by Chen et al21 
states that interventions aiming to empower people with 
chronic illnesses are able to improve health status, improve 
outcome indicators of psychological and social aspects, 
and improve self-management. The authors of the DAWN 
MIND study suggest further research on process evalua-
tions to explore the role of empowerment-centred and 
patient-centred skills such as active listening, use of open-
ended questions and promoting active patient participa-
tion in the decision-making process.14
The overarching aim of the Diabetes Patient-Reported 
Outcome Measures trial (DiaPROM trial) is to develop, 
test and evaluate a structured empowerment-based 
intervention using PROMs regarding diabetes distress 
as dialogue support in clinical diabetes consultations 
among adults with T1D. Our proposition is that the 
DiaPROM intervention initiative will reduce diabetes 
distress and further improve overall well-being, improve 
perceived competence for diabetes management and 
improve glycaemic control. Based on experiences and 
research,14 18 19 we also believe that improved focus on the 
psychological and emotional burden of the disease will 
improve satisfaction with diabetes follow-up. This paper 
describes the protocol for a pilot randomised controlled 
trial (RCT) to test the feasibility of and uncertainties asso-
ciated with a fully powered evaluation study.
the development of the diaProM trial
The DiaPROM trial is part of the implementation of 
PROMs in the Norwegian Diabetes Register for Adults. 
We wanted to design a study to test a method for using 
the PROMs data in clinical diabetes practice. The study 
is multidisciplinary and consists of several interacting 
components and a number of behaviours required by 
those receiving and delivering the intervention. Thus, 
we consider the study as a complex intervention with a 
need to develop and test the various components gradu-
ally before conducting a fully powered RCT. As guidance 
in this process, we used the Medical Research Coun-
cil’s framework (MRC framework) for the evaluation of 
complex interventions.22 23 The framework describes four 
important phases in the development, evaluation and 
implementation of a new intervention initiative: (1) the 
development phase, (2) the feasibility and piloting phase, 
(3) the evaluation phase and (4) the implementation 
phase (figure 1).
The development of the DiaPROM trial took place 
during 2016 and 2017. Initially, the essential tasks were 
to determine which PROMs to include and how patients 
should complete the PROMs.
ProMs to include
We reviewed the literature to identify published articles on 
the use of PROMs as dialogue support in clinical diabetes 
practice. We wanted to identify the most commonly used 
PROMs to measure diabetes distress. We recognised that 
studies have primarily used PROMs to evaluate interven-
tions’ effects; relatively few publications have reported 
on the use of PROMs in clinical diabetes care. We did 
identify, however, the DAWN MIND study which tested 
the feasibility and impact of the computer-assisted ‘Moni-
toring of Individual Needs in Diabetes’ procedure aimed 
to improve recognition and management of the psycho-
logical needs of patients with diabetes by implementing 
PROMs in routine diabetes care.14 24 Regular assessment 
of psychological needs was implemented as part of the 
annual review in diabetes clinics across eight countries. 
The assessment included, among others, diabetes distress 
measured by the Problem Areas in Diabetes (PAID) scale. 
Accordingly, Schmitt et al25 emphasise the necessity of 
a justified choice of measurement and recommend the 
use of the PAID when the clinical purpose is to bear in 
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mind a variety of emotional concerns related to living 
with diabetes. Some other studies have reported PAID 
as an appropriate instrument for use in clinical diabetes 
consultations, as well.26–30 The scale may contribute 
to improved communication by making the dialogue 
between healthcare providers and patients more thera-
peutic and goal-oriented.
Patient and public involvement
Involving health service users throughout all phases 
of a study is important to provide insight into patients’ 
perspectives and ensure that the research focuses on 
issues relevant for the health service users and the 
public.31 32 Patient and public involvement (PPI) is also 
useful in terms of shaping the research processes.31 In 
this study, we used the Guidance for Reporting Involve-
ment of Patients and the Public 2 (GRIPP2) short form 
as guidance for including and reporting PPI.32 To include 
the voice of the health service users throughout the 
study, two people with diabetes have been included in the 
DiaPROM project group, both experienced with PPI and 
research. They will contribute to all phases of the study. 
Furthermore, we have included additional people with 
diabetes to share their views on the various phases of the 
study, recruited mainly from national and local diabetes 
associations.
A crucial question when we considered which PROMs 
to include in the study was what adult people with T1D 
perceived as the most important and relevant aspects to 
emphasise in diabetes follow-up. Thus, in parallel with the 
literature review, we consulted the health service users. In 
addition to the health service users in the project group, 
we met the leader of the Norwegian Diabetes Associa-
tion and a group of four representatives from the local 
diabetes association (two with T1D and two parents of 
children with T1D where one had type 2 diabetes herself). 
First, we used open question to the health service users 
to determine which topics they perceived as important 
and relevant to include in a set of PROMs. After an 
open discussion, we asked them to review several generic 
instruments (eg, WHO’s 5-Item Well-Being Index [WHO-
5], RAND-12 Health Status Inventory, Patient Activation 
Measure) and diabetes-specific instruments (eg, PAID, 
Diabetes Distress Scale [DDS], Perceived Competence for 
Diabetes Scale [PCDS]). The user representatives consid-
ered the advantages and shortcomings of using the 20 
statements in PAID as dialogue support in the interven-
tion. They found the instrument relevant and suitable to 
be used in the intervention.
the PAId
Based on the literature review and in accordance with the 
input from the health service users, we chose the PAID 
scale for use in the study intervention. The participants’ 
PAID scores will constitute the basis for the dialogue in 
the clinical consultations. The scale was developed to gain 
insight into the breadth of emotional responses to living 
with diabetes and consists of 20 statements regarding 
diabetes distress (eg, ‘feeling constantly concerned about 
food and eating’, ‘worrying about low blood sugar reac-
tions’).33–35 The scores are on a 5-point Likert scale from 
0 (not a problem) to 4 (serious problem). An item score 
of 3 (somewhat serious problem) or 4 (serious problem) 
indicates moderate to serious diabetes distress related to 
the specific item. Scale scores are transformed to a 0–100 
scale, with higher scores indicating greater distress, and 
a PAID total score >40 suggests serious diabetes-related 
distress. To identify both moderate and serious distress, 
we defined scores of concern as PAID total scores ≥30 or 
single item scores of 3 or 4. The scale has been translated 
into several languages, including Norwegian.36
Method for completing ProMs
The literature describes various methods for adminis-
tration of PROMs, such as paper-based self-administra-
tion at home or in the clinic, interviews by telephone or 
personal meetings, computer-assisted self-administration 
in the clinic, or mail-based or web-based administration 
from patients’ homes.16 17 Electronic PROMs collection is 
preferred since the patients’ responses can be transferred 
Figure 1 Key elements in the Medical Research Council’s guidance for developing, evaluating and implementing complex 
interventions (MRC framework). Reproduced from Craig et al22  with permission.
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to the electronic patient records (EPRs) without scanning 
paper forms or punching data.17 In our study, we decided 
on computer-assisted administration on a touchscreen 
computer in the outpatient clinic. Using this method has 
advantages, such as efficient and simultaneous data entry 
and minor privacy challenges.
Feasibility study
We conducted a feasibility study in 2017 to examine the 
technical and practical feasibility of collecting PROMs 
on a touchscreen computer in the outpatient clinic, and 
evaluate the participants’ perceived understanding and 
relevance of the items on the PAID and the included 
outcome measures. We also evaluated the acceptability 
of completing PROMs annually. Field observations and 
comments from the participants provided data on the 
technical and practical procedures. Sixty-nine individuals 
with T1D ≥40 years participated in the study and 83% of 
them reported that, to a high or a very high degree, they 
would be positive about an annual completion of PROMs. 
However, almost 20% of 137 invited patients did not show 
up at the clinic (change of appointments, sick, no reason 
given), and most of the invited ones did not go directly 
to the computer on arrival at the clinic as instructed in 
the information sheet. Thus, we developed clearer infor-
mation and procedures for the pilot study to avoid loss of 
potential participants among those invited. Further anal-
yses of the results from the feasibility study are ongoing, 
and we plan to publish these in a separate article.
Aims
The purpose of the pilot RCT reported here is to test the 
feasibility of the proposed DiaPROM trial components 
and address the uncertainties associated with running a 
fully powered RCT in order to conclude whether such a 
trial is appropriate and/or feasible. The following are our 
objectives:
1. Evaluate the recruitment procedures and attrition 
rates.
2. Evaluate the performance of the randomisation pro-
cedure.
3. Evaluate the participants’ mean scores on the outcome 
measures before and after the intervention.
4. Evaluate if the intervention consultations are accept-
able and feasible.
5. Explore patients’ and healthcare providers’ experi-
ences with the use of PAID as dialogue support and 
empowerment-based communication skills in clinical 
diabetes consultations.
MEthods And AnAlysIs
We will undertake a two-arm pilot RCT with embedded 
qualitative study on participants’ and healthcare 
providers’ views of the DiaPROM intervention initiative. 
We report our protocol here using the Standard Protocol 
Items: Recommendations for Interventional Trials 
checklist (http://www. spirit- statement. org/ wp- content/ 
uploads/ 2013/ 01/ SPIRIT- Checklist- download- 8Jan13. 
pdf).
Participants and eligibility criteria
As recommended for pilot RCTs,37 we will include 
80 participants: 40 in the intervention group and 40 
controls. Participants will have T1D for at least 1 year and 
be aged ≥18 to <40 years. We will exclude people who are 
unable to read or complete the PROMs on the touch-
screen computer. Furthermore, we will exclude pregnant 
women, patients with known and recorded cognitive defi-
ciency (eg, Down’s syndrome, Alzheimer), severe somatic 
comorbidity (eg, end-stage renal disease, severe heart 
failure, severe cancer), and/or a major psychiatric diag-
nosis (eg, severe depression or bipolar disorder, schizo-
phrenia) as diabetes distress is often neither ethical nor 
possible to discuss with these groups of patients. Eligible 
participants will receive information and consent forms 
by regular mail before their annual diabetes consultation 
at the clinic. The information form will include informa-
tion about the possibility to withdraw from the study at 
any time point without consequences.
randomisation procedure and allocation concealment
We will randomise eligible and consenting participants, 
using computer-generated block randomisation at the 
patient level, stratified for gender, immediately after the 
participants have completed both the PAID and the self-re-
ported outcome measures. When participants complete the 
measures on the touchscreen computer in the outpatient 
clinic, they will receive an individual four-character code. 
When the physician downloads the PROMs data using the 
code, a concealed computerised allocation will take place. 
Information about which group the person is allocated to 
will appear on the computer screen and the physician will 
inform the participant immediately. It is not possible to 
blind either participants or healthcare providers.
trial intervention
After participants have completed the PAID scale, physi-
cians download the scores into the participants’ EPR as 
part of the annual consultation (figure 2). Physicians then 
review and discuss the PAID scores briefly with the partici-
pants. Participants with one or more single PAID item(s) 
score of 3 or 4 (somewhat serious or serious problem), 
or PAID total score ≥30, will be referred to additional 
diabetes nurse consultations. Participants with lower 
scores will receive regular follow-up according to usual 
clinical protocols.
Additional nurse follow-up will consist of at least two 
consultations. The first will take place within 4 weeks after 
randomisation, and the second within a further 3 months. 
After the second nurse consultation, the nurse and the 
participant will agree any further follow-up until the next 
annual consultation with the physician. Diabetes nurses 
will review the PAID scores and discuss the reported 
problem areas and distress with participants by following 
a communication manual based on key elements from 
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empowerment theory and self-determination theory, such 
as empathetic communication and autonomy support.38–40 
These communication skills involve ‘active listening’, 
‘asking open questions’, ‘responding’, ‘summing up’ 
and ‘agreeing on goals and actions to take’. Nurses will 
record their work on participants’ problem areas, goals 
and actions. The intervention will last for a maximum of 
1 year, until the next annual consultation.
Control procedure
The control group will receive ‘care as usual’, which 
does not include a structured focus on psychological 
and emotional diabetes distress. For most patients the 
annual consultation normally constitutes ‘care as usual’. 
Although all participants will complete the PAID before 
randomisation, for control participants the scores will not 
be accessible to clinicians in the EPR until the study is 
completed. For ethical reasons, we will not prevent physi-
cians discussing psychological or emotional issues with 
participants in the control group if participants specifi-
cally raise such an issue. Unlike participants in the inter-
vention group, such discussions will not be structured 
with reference to the PAID data. We will identify to what 
extent such discussions have taken place by reviewing 
participants’ EPR.
training of healthcare providers
Before the study commences, we will have a 1-hour 
meeting with the participating physicians, and they will 
be trained in how to download the PAID scores into the 
EPR and how to briefly discuss the scores in the annual 
consultations. Further, they will get both oral information 
and written instructions regarding the interpretation of 
the PAID scores including instructions on the criteria for 
referral of participants to extra follow-up by the diabetes 
nurses. Nurses will get both oral and written information 
and a 2×1 hour training in how to interpret scores and 
discuss the reported problem areas, how to follow the 
communication manual in the consultations, and how to 
agree on goals and actions to take with the participants.
data collection and outcome measures
All participants (both intervention and control groups) 
will complete the outcome measures electronically 
before the annual consultation at baseline and after 12 
months. After the annual consultation, the participants 
will complete a paper-based questionnaire about their 
experience and satisfaction with the diabetes follow-up. 
We will evaluate the recruitment procedures and attrition 
rates by observing and monitoring the number of eligible 
participants invited, number of invited people declining 
participation, number of people who attended the clinic, 
number of intervention participants who attended 
the nurse consultations and number of consultations 
conducted. We will also observe and document the tech-
nical performance of the randomisation procedure. 
Finally, we will document all types of contacts between 
participants and the diabetes outpatient clinic for all 
participants throughout the study period.
To describe the study sample and evaluate the technical 
procedure of data retrieval from EPR, we will perform a 
computerised retrieval of the following variables from the 
participants’ EPR: sex, age, ethnicity, body mass index, 
diabetes duration, haemoglobin A1c (HbA1c) (secondary 
outcome), insulin regimen, insulin doses, severe hypogly-
caemic episodes needing assistance in the past year, hospi-
talisations, comorbidities and diabetes late complications.
The outcome measures to evaluate the effect of the 
intervention in the evaluation phase of the study (phase 
Figure 2 The study intervention in the Diabetes Patient-Reported Outcome Measures trial (DiaPROM). PAID, Problem Areas In 
Diabetes scale.
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III) were chosen based on a literature review and consid-
erations among the researchers and the health service 
users. We decided on the DDS as primary outcome. 
DDS measures diabetes distress and contains 17 items 
and 4 subscales: emotional burden (five items), physi-
cian-related distress (four items), regimen distress (five 
items) and diabetes-related interpersonal distress (three 
items).41 The scores are on a 6-point Likert scale from 
1 (not a problem) to 6 (serious problem), with a mean 
total or subscale score from 1 to 6.42 The total or subscale 
scores >3 are defined as high levels of distress. The DDS 
has previously shown satisfactory psychometric properties 
to map diabetes distress and might have advantages for use 
as outcome measure in clinical trials because it contrib-
utes to identification of subdomains of distress.11 25 36 To 
measure the secondary outcomes, overall well-being and 
perceived diabetes competence, we have included the 
WHO-543–45 and the PCDS.46–48 We will use HbA1c as the 
target for glycaemic control.
We will invite all participants from the intervention 
group and all healthcare providers (physicians and 
diabetes nurses) participating in the intervention group 
to individual indepth interviews to collect qualitative data 
on their experiences with the intervention, including the 
use of PAID as dialogue support in clinical consultations. 
This will provide a sample of about 15–20 participants 
and 10–15 healthcare providers. All interviews will be 
conducted at the outpatient clinic and will be audio-re-
corded after obtaining consent from participants.
data analysis
We will use Stata SE V.15 for Windows for all statistical 
analyses,49 and for data entry range checks for data values 
will be performed. We will report the recruitment of 
participants and the number of trial dropouts descrip-
tively (frequencies and percentages). Further, we will 
report the means, SD and CI of the DDS and the other 
outcome measurements before and after the intervention 
period for both the intervention and control groups. As 
the study is a pilot and the sample size is small, we will not 
perform inferential statistics and analyse between-group 
calculations. The participants’ PAID scores will be anal-
ysed descriptively (mean, SD), as well.
We will transcribe verbatim and analyse participants’ 
and healthcare providers’ experiences with the interven-
tion by using thematic analysis.50 Thematic analysis is a 
flexible qualitative method without any specific theoret-
ical foundation and consists of six steps: (1) transcribing, 
reading and rereading, (2) generating initial codes, (3) 
searching for themes, (4) reviewing themes, (5) defining 
and naming the themes, and (6) producing the report.
EthICs And dIssEMInAtIon
Haukeland University Hospital, Bergen, Norway, is the 
responsible research institution (trial sponsor) where the 
study data will be stored on a secure research server. In 
order to protect confidentiality, names of the potential 
and enrolled participants will be stored separate from 
the other study data. Only the principal investigator and 
other clearly identified members of the project group 
have access to the study data. If important protocol modi-
fications happen, this will be communicated to the ethics 
committee and  ClinicalTrials. gov. Further information 
can be obtained from  ClinicalTrials. gov, trial registration 
number NCT03471104.
Completing the PROMs may activate latent psycholog-
ical or psychosocial problems and negative feelings. To 
care for any participants in the control group reporting 
worryingly high levels of distress (eg, above cut points for 
severe levels of distress measured by PAID and/or DDS), 
the research team will continuously review the reported 
distress levels. We will discuss potential needs for more 
intensive care or referral to psychological or psychiatric 
follow-up for those reporting worryingly levels of distress 
with the physicians and diabetes nurses.
We will present the findings of the study phases at 
national and international conferences and submit manu-
scripts to peer-reviewed journals and popular science jour-
nals. Further, we will also publish the findings in popular 
science journals, public newspapers and journals for rele-
vant health service user groups. One of the health service 
users included in the project group will participate in the 
writing and publication process.
dIsCussIon
In the pilot RCT study described in this protocol, we aim 
to test the feasibility of and address the clinical and meth-
odological uncertainties associated with running a fully 
powered RCT testing the effect of an intervention incor-
porating the use of PAID to decrease diabetes distress 
among people with T1D. The study will provide knowl-
edge on the use of PAID in clinical diabetes practice, 
although the purpose primarily is to prepare the ground 
for the design and conduct of a fully powered RCT. In 
addition, the qualitative evaluation will provide important 
knowledge on the specific empowerment-based commu-
nication skills used to discuss PAID scores of concern in 
the clinical consultations. In an upcoming fully powered 
evaluation study (phase III), we plan to test the effect of 
the entire intervention package including both the use 
of PAID and the empowerment-based follow-up. A major 
limitation of such an effect study is the lack of informa-
tion on how specific parts of the intervention may affect 
the results.
Diabetes distress has been shown to be a barrier to satis-
factory glycaemic control,11 12 and a more structured focus 
on diabetes distress may have the potential to improve 
long-term health for people with T1D by reducing distress 
and improving glycaemic control. A previous literature 
review by Carlsen et al51 found that the use of PAID could 
benefit patients but emphasised the need for follow-up 
studies to evaluate whether the PAID should be imple-
mented in routine diabetes care to enhance a more struc-
tured focus on diabetes distress.
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The choice of using PAID as dialogue support in the 
intervention and the DDS as the primary outcome measure 
is in accordance with previous research. Both instruments 
have previously shown satisfactory psychometric proper-
ties to map individual levels of diabetes distress, but it 
has been claimed that the PAID has advantages for use in 
clinical practice and that the DDS has advantages for use 
in clinical trials, because it also contributes to identifying 
subdomains of distress.11 25 36 However, there will be an 
overlap between the intervention measure (PAID) and 
the primary outcome measure (DDS) in this study. Using 
PAID in the intervention may prime the participants’ 
responses to the DDS, but the inclusion of WHO-5 and 
the PCDS as additional outcomes may compensate for the 
overlap between PAID and DDS. Previous research has 
shown links between diabetes distress measured by PAID, 
and well-being and perceived competence. Snoek et al14 
indicated an overlap between predictors for diabetes 
distress and general well-being measured by WHO-5, 
and Mohn et al48 showed an association between greater 
diabetes distress and lower perceived competence for 
diabetes self-management measured by PCDS.
strengths and limitations
The use of the MRC framework is a strength in the devel-
opment of this study because it includes several complex 
and interacting components that need to be considered 
and tested with the purpose to reveal uncertainties before 
conducting a fully powered RCT. In addition, the use of 
the GRIPP2 short form to guide the PPI throughout all 
phases of the development of the intervention initiative is 
considered a strength. The health service users included 
in the project have influenced, among others, the choice 
of PROMs, the choice of the theoretical foundation for 
the intervention and the discussions related to the quali-
tative component of the study.
We have included primarily disease-specific outcome 
measures, but also one generic PROM (WHO-5). 
Disease-specific PROMs are used to capture informa-
tion that is most pertinent to particular patient groups, 
but they might miss domains affecting the patient that 
are unrelated to their disease.16 52 Generic instruments 
may capture broad dimensions of health and allow for 
comparisons between populations but might not be sensi-
tive to changes in disease-specific health domains over 
time or in relation to interventions.15
The fact that the control group in the study will also 
complete the PAID and the evaluation PROMs before the 
annual diabetes consultation, and that the same physi-
cians meet participants from both the intervention and 
the control groups, might lead to intervention contami-
nation challenges. This might be a challenge, although 
the scores will not be accessible in the EPRs of partici-
pants in the control group.
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